Group name
NADT
Groups remarks
neoadjuvant androgen deprivation therapy
T2a
2 (1.5)
T2b
1 (0.7)
T2c
49 (35.8)
T3a
28 (20.4)
>T3b
57 (41.6)
T4
0 (0)
remark
Pathological stage: n (%)
GS 2-6
9 (6.5)
GS 3+4
34 (24.6)
GS 4+3
25 (18.1)
GS 9-10
46 (33.3)
remark
Pathologic GS: median (range)